Influence of albumin dialysis on pharmacokinetics of amphotericin B colloidal dispersion and amphotericin B lipid complex

Artificial Organs

Volumn 35, Issue 6, 2011, Pages 667-671

  Weiler, Stefan ^a   Vogelsinger, Helene ^a   Joannidis, Michael ^a   Dunzendorfer, Stefan ^a   Bellmann, Romuald ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Amphotericin B colloidal dispersion; Extracorporeal blood purification; Lipid complex; Molecular adsorbent recirculating system

Indexed keywords

ANTIMICROBIAL AGENTS; ARTIFICIAL ORGANS; DIALYSIS; DISPERSIONS; PHARMACOKINETICS;

AMPHOTERICIN B; AMPHOTERICIN B COLLOIDAL DISPERSION; BLOOD PURIFICATION; COLLOIDAL DISPERSION; EXTRACORPOREAL BLOOD PURIFICATION; LIPID COMPLEXES; LIVER FAILURE; MOLECULAR ADSORBENT RECIRCULATING SYSTEM; PHARMACOKINETIC DATA; RECIRCULATING SYSTEM;

PATIENT TREATMENT;

AMPHOTERICIN B CHOLESTEROL SULFATE; ANTIFUNGAL AGENT; LIPID;

ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALBUMIN DIALYSIS; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DISEASE; CASE REPORT; CLEARANCE; DRUG ELIMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER FAILURE; MALE; MYCOSIS; PRIORITY JOURNAL; SOLID PHASE EXTRACTION;

EID: 79958852948     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.2010.01111.x     Document Type: Article

References (20)

1. Kapoor D. Molecular adsorbent recirculating system: albumin dialysis-based extracorporeal liver assist device. J Gastroenterol Hepatol 2002;17:S280-6.
2. Sen S, Mookerjee RP, Davies NA, Williams R, Jalan R. Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Aliment Pharmacol Ther 2002;16:32-8.
3. Mitzner SR. Albumin dialysis: an update. Curr Opin Nephrol Hypertens 2007;16:589-95.
4. Saliba F. The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure. Crit Care 2006;10:118.
5. Bañares R, Nevens F, Larsen FS, etal. Extracorporeal liver support with the molecular adsorbent recirculating system (MARS) in patients with acute-on-chronic liver failure (AoCLF). J Hepatol 2010;53:S459-60.
6. Prodanovic H, Cracco C, Massard J, etal. Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series. BMC Gastroenterol 2007;7:2.
7. Meersseman W, Lagrou K, Maertens J, Van Wijngaerden E. Invasive aspergillosis in the intensive care unit. Clin Infect Dis 2007;45:205-16.
8. Bellmann R, Egger P, Pechlaner C, etal. Levofloxacin elimination during albumin dialysis. Int J Artif Organs 2003;26:358-59.
9. Vogelsinger H, Joannidis M, Kountchev J, Bellmann-Weiler R, Wiedermann CJ, Bellmann R. Pharmacokinetics of liposomal amphotericin B during extracorporeal albumin dialysis. Artif Organs 2006;30:118-21.
10. Boswell GW, Buell D, Bekersky I. AmBisome (liposomal amphotericin B): a comparative review. J Clin Pharmacol 1998;38:583-92.
11. Adler-Moore JP, Proffitt RT. Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B. J Liposome Res 1993;3:429-50.
12. Egger P, Bellmann R, Wiedermann CJ. Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001;760:307-13.
13. Bellmann R, Egger P, Gritsch W, etal. Amphotericin B lipid formulations in critically ill patients on continuous veno-venous haemofiltration. J Antimicrob Chemother 2003;51:671-81.
14. Bellmann R, Egger P, Djanani A, Wiedermann CJ. Pharmacokinetics of amphotericin B lipid complex in critically ill patients on continuous veno-venous haemofiltration. Int J Antimicrob Agents 2004;23:80-3.
15. Wang LH, Fielding RM, Smith PC, Guo LS. Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and Fungizone after repeated dosing in rats. Pharm Res 1995;12:275-83.
16. Duflo F, Allaouchiche B, Chassard D. Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex. Scand J Infect Dis 2000;32:581.
17. Vogelsinger H, Weiler S, Djanani A, etal. Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion. J Antimicrob Chemother 2006;57:1153-60.
18. Frothingham R. Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia. Clin Infect Dis 2002;35:896-97.
19. Bellmann R, Egger P, Wiedermann CJ. Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence. Clin Infect Dis 2003;36:1500-01.
20. Majcher-Peszynska J, Peszynski P, Müller SC, etal. Drugs in liver disease and during albumin dialysis-MARS. Z Gastroenterol 2001;39:33-5.